Amgen sales rise 4% in first quarter, submits label update to FDA on autoimmune drug
Amgen sales rise 4% in first quarter, submits label update to FDA on autoimmune drug
Related Posts
Popular News
-
35 Best Hotels in New York City We Won’t Shut Up About
-
7 Wearable Makeup Trends That’ll Be Everywhere In 2025
-
Asda to buy UK operations of petrol chain operator EG Group in £2.3bn deal
-
Trump TRUMP Memecoin Gala at Mar-a-Lago
-
‘I hope to retire early’: I’m 56 and have 80% in a traditional IRA and 20% in a Roth. Am I in trouble?
Latest News
Stocks clock their best month since 2020 as Wall Street shakes off Iran oil shock
The S&P 500 and Nasdaq composite just tallied their best month in six years, surprising the bears focused on oil...
Amazon Prime Day Is Coming Early This Year
Amazon Prime Day 2026 is sure to be the biggest online sale of the year, and it's coming a bit...
Dollar slides as Iran ceasefire unwinds safe‑haven trade
The dollar index is heading for its biggest monthly drop since June 2025 as U.S.–Iran ceasefire hopes unwind the war...
Amgen sales rise 4% in first quarter, submits label update to FDA on autoimmune drug
Amgen sales rise 4% in first quarter, submits label update to FDA on autoimmune drug
Welcome to Global Finances Daily, your go-to source for all things finance. Our mission is to provide our readers with valuable information and insights to help them achieve their financial goals and secure their financial future.